LXPA1788
/ LaunXP Biomedical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 19, 2025
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: LaunXP Biomedical Co., Ltd.
New P1 trial • Genito-urinary Cancer • Hepatocellular Cancer • Hepatology • Oncology • Pancreatic Cancer • Renal Cell Carcinoma • Solid Tumor
1 to 1
Of
1
Go to page
1